These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3090984)

  • 1. [Valproic acid, curly hair and weight gain].
    Bittencourt PR
    Arq Neuropsiquiatr; 1986 Mar; 44(1):78-81. PubMed ID: 3090984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valproic acid in childhood epilepsy: anticonvulsive efficacy in relation to its plasma levels.
    Klotz U; Schweizer C
    Int J Clin Pharmacol Ther Toxicol; 1980 Oct; 18(10):461-5. PubMed ID: 6782028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of ghrelin in weight gain and growth in epileptic children using valproate.
    Gungor S; Yücel G; Akinci A; Tabel Y; Ozerol IH; Yologlu S
    J Child Neurol; 2007 Dec; 22(12):1384-8. PubMed ID: 18174556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The scope and use of valproate in epilepsy.
    Penry JK; Dean JC
    J Clin Psychiatry; 1989 Mar; 50 Suppl():17-22. PubMed ID: 2494154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproic acid. A reappraisal of its pharmacological properties and clinical efficacy in epilepsy.
    Davis R; Peters DH; McTavish D
    Drugs; 1994 Feb; 47(2):332-72. PubMed ID: 7512905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epileptic seizures caused by low valproic acid levels from an interaction with meropenem.
    Fudio S; Carcas A; Piñana E; Ortega R
    J Clin Pharm Ther; 2006 Aug; 31(4):393-6. PubMed ID: 16882111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of valproic acid-associated weight gain in prepubertal children.
    Espinosa PS; Salazar JC; Yu L; Mendiondo MS; Robertson WC; Baumann RJ
    Pediatr Neurol; 2008 Sep; 39(3):177-80. PubMed ID: 18725062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute seizures due to a probable interaction between valproic acid and meropenem.
    Coves-Orts FJ; Borrás-Blasco J; Navarro-Ruiz A; Murcia-López A; Palacios-Ortega F
    Ann Pharmacother; 2005 Mar; 39(3):533-7. PubMed ID: 15701769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma concentrations of sodium valproate: their clinical value.
    Turnbull DM; Rawlins MD; Weightman D; Chadwick DW
    Ann Neurol; 1983 Jul; 14(1):38-42. PubMed ID: 6412620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seizure control and side-effect profile after switching adult epileptic patients from standard to extended-release divalproex sodium.
    Pierre-Louis SJ; Brannegan RT; Evans AT
    Clin Neurol Neurosurg; 2009 Jun; 111(5):437-41. PubMed ID: 19181439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy.
    Kothare SV; Valencia I; Khurana DS; Hardison H; Melvin JJ; Legido A
    Epileptic Disord; 2004 Dec; 6(4):267-70. PubMed ID: 15634623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Juvenile myoclonic epilepsy.
    Kibria EM
    J Am Osteopath Assoc; 1993 Jan; 93(1):126-8. PubMed ID: 8423123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leptin, ghrelin, and adiponectin in epileptic patients treated with valproic acid.
    Greco R; Latini G; Chiarelli F; Iannetti P; Verrotti A
    Neurology; 2005 Dec; 65(11):1808-9. PubMed ID: 16344528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combination therapy with carbamazepine and valproic acid in problem cases at an outpatient epilepsy clinic].
    Fröscher W; Stoll KD; Hoffmann F
    Arzneimittelforschung; 1984; 34(8):910-4. PubMed ID: 6437416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valproic acid (Depakene). A new anticonvulsant agent.
    Lewis JR
    JAMA; 1978 Nov; 240(20):2190-2. PubMed ID: 100622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Valproate sustained release in the treatment of epilepsy].
    Stefan H; Fraunberger B
    Fortschr Neurol Psychiatr; 2005 Nov; 73(11):681-6. PubMed ID: 16283612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sodium valproate (Na VPa) monotherapy in childhood epilepsy ].
    Dulac O; Steru D; Rey E; Arthuis M
    Arch Fr Pediatr; 1982; 39(6):347-52. PubMed ID: 6812534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'Perming' effects associated with chronic valproate therapy.
    Gupta AK
    Br J Clin Pract; 1988 Feb; 42(2):75-7. PubMed ID: 3140865
    [No Abstract]   [Full Text] [Related]  

  • 19. Conversion from delayed-release sodium valproate to extended-release sodium valproate: initial results and long-term follow-up.
    McCabe PH; Michel NC; McNew CD; Lehman EB
    Epilepsy Behav; 2006 May; 8(3):601-5. PubMed ID: 16678766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-related metabolic changes during treatment with valproate in patients with epilepsy.
    Pylvänen V; Pakarinen A; Knip M; Isojärvi J
    Epilepsy Behav; 2006 May; 8(3):643-8. PubMed ID: 16600693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.